Exploring Resistance Exercise Training Plus High-Intensity Interval Training (ReHIIT) as Cancer P… (NCT07313332) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Exploring Resistance Exercise Training Plus High-Intensity Interval Training (ReHIIT) as Cancer Prehabilitation
United Kingdom14 participantsStarted 2026-01-01
Plain-language summary
Colorectal cancer is the fourth most common cancer in the UK. Prehabilitation, including exercise, can improve recovery from surgery. This pilot study investigates the combined effects of resistance and high-intensity interval training (ReHIIT) in healthy adults to establish baseline physiology and responses for comparison with cancer patients
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participant is willing and able to give informed consent for participation in the study.
* Availability and willingness to attend the Royal Derby Hospital site for a minimum of 8 exercise sessions and 2 assessment sessions across the study period.
Exclusion Criteria:
* BMI \<18 or \>35 kg/m2
* Known active cance
* Known metabolic disease
* Current known neurological or musculoskeletal conditions (e.g. epilepsy)
* Active known cardiovascular, cerebrovascular or respiratory disease - e.g:
* Uncontrolled hypertension (systolic BP \> 160 mmHg or diastolic BP \>100 mmhg)
* Myocardial infarction within the last 6 months or unstable angina
* Heart failure (New York Heart association Class III/IV)
* Arrhythmia
* Right to left cardiac shunt
* Aneurysm of a named blood vessel
* COPD
* Pulmonary hypertension
* Exercise-induced or brittle asthma
* Previous stroke/transient ischaemic attack
* Abnormal ECG results (at the discrepancy of the study doctor)
* Patients who are unable to undergo CPET based on ATS/ACSS guidelines \^
* Pre-existing clotting disorder known to the participant or anticoagulant use
* Family history of severe bleeding requiring medical intervention
* Participation in a research study in the last 3 months involving invasive procedures or an inconvenience allowance (ALL UoN FMHS UREC approved studies)
* Pregnant or breastfeeding
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in anaerobic threshold (CPET-derived)
Timeframe: From baseline to 4-weeks after the start of the intervention
2
Change in Muscle mass
Timeframe: From baseline to 4-weeks after the start of the intervention